Agrawal Yash N and Fernandez-Martinez Aranzazu and Gil-Gil Miguel and Zielinski Christoph and Ruiz-Borrego Manuel and Ciruelos Eva Maria and Munoz Montserrat and Margeli Mireia and Bermejo Begona and Anton Antonio and Kahán Zsuzsanna and Csöszi Tibor and Alonso-Romero Jose Luis and Garcia-Saenz Jose Angel and Sanchez-Rovira Pedro and Alvarez Elena and Chacon Jose Ignacio and Gonzalez-Santiago Santiago and Rodriguez Cesar A and Servitja Sonia and Pfefferle Adam D and Herranz Jesus and Liu Yuan and Carey Lisa A and Romero-Camarero Isabel and Caballero Rosalia and Guerrero-Zotano Angel and Perou Charles M and Martin Miguel:
Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial.
JCO PRECISION ONCOLOGY, 9.
ISSN 2473-4284
(2025)
Martin Miguel and Zielinski Christoph and Ruiz-Borrego Manuel and Carrasco Eva and Ciruelos Eva M. and Munoz Montserrat and Bermejo Begona and Margeli Mireia and Csoszi Tibor and Anton Antonio and Turner Nicholas and Casas Maria I and Morales Serafin and Alba Emilio and Calvo Lourdes and De La Haba-Rodriguez Juan and Ramos Manuel and Murillo Laura and Santaballa Ana and Alonso-Romero Jose L. and Sanchez-Rovira Pedro and Corsaro Massimo and Huang Xin and Thallinger Christiane and Kahán Zsuzsanna and Gil-Gil Miguel:
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study.
EUROPEAN JOURNAL OF CANCER, 168.
pp. 12-24.
ISSN 0959-8049
(2022)